Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| BRCA1 Protein | 10 | 2026 | 70 | 1.840 |
Why?
|
| DNA Replication | 4 | 2025 | 249 | 1.780 |
Why?
|
| BRCA2 Protein | 4 | 2026 | 20 | 1.740 |
Why?
|
| Ovarian Neoplasms | 4 | 2026 | 170 | 1.260 |
Why?
|
| DNA Damage | 8 | 2023 | 298 | 1.210 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2026 | 17 | 1.200 |
Why?
|
| DNA Repair | 9 | 2023 | 263 | 1.050 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2025 | 36 | 0.920 |
Why?
|
| Genomic Instability | 1 | 2025 | 59 | 0.890 |
Why?
|
| Cytidine Deaminase | 1 | 2025 | 86 | 0.870 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 25 | 0.700 |
Why?
|
| Haploinsufficiency | 2 | 2024 | 20 | 0.650 |
Why?
|
| Replication Protein A | 1 | 2020 | 14 | 0.640 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 94 | 0.630 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 226 | 0.610 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 314 | 0.590 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 18 | 0.560 |
Why?
|
| Bacteriophage mu | 4 | 2004 | 8 | 0.490 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 1567 | 0.470 |
Why?
|
| Genes, BRCA1 | 1 | 2014 | 18 | 0.440 |
Why?
|
| Fallopian Tubes | 2 | 2025 | 13 | 0.430 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 410 | 0.400 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2025 | 7 | 0.390 |
Why?
|
| Ultraviolet Rays | 3 | 2023 | 153 | 0.390 |
Why?
|
| Epithelial Cells | 3 | 2023 | 413 | 0.380 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2004 | 119 | 0.370 |
Why?
|
| DNA Transposable Elements | 3 | 2004 | 160 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 708 | 0.350 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 2305 | 0.330 |
Why?
|
| Rad51 Recombinase | 3 | 2020 | 33 | 0.290 |
Why?
|
| Transposases | 3 | 2004 | 18 | 0.290 |
Why?
|
| Heterozygote | 2 | 2021 | 173 | 0.270 |
Why?
|
| DNA Helicases | 3 | 2020 | 198 | 0.270 |
Why?
|
| DNA, Superhelical | 4 | 2004 | 8 | 0.260 |
Why?
|
| Cell Cycle | 3 | 2020 | 398 | 0.240 |
Why?
|
| APOBEC Deaminases | 1 | 2025 | 11 | 0.230 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2025 | 27 | 0.230 |
Why?
|
| Humans | 18 | 2026 | 65463 | 0.230 |
Why?
|
| Germ-Line Mutation | 2 | 2024 | 47 | 0.230 |
Why?
|
| Mutation | 5 | 2026 | 2666 | 0.220 |
Why?
|
| Mice | 5 | 2024 | 11138 | 0.220 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 46 | 0.220 |
Why?
|
| DNA, Viral | 2 | 2004 | 232 | 0.220 |
Why?
|
| Precancerous Conditions | 1 | 2025 | 74 | 0.220 |
Why?
|
| DNA, Single-Stranded | 1 | 2025 | 108 | 0.210 |
Why?
|
| Female | 10 | 2026 | 34193 | 0.210 |
Why?
|
| Sesquiterpenes | 1 | 2023 | 5 | 0.200 |
Why?
|
| Chromosome Pairing | 1 | 2003 | 7 | 0.200 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 22 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 205 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2023 | 115 | 0.180 |
Why?
|
| Zebrafish Proteins | 1 | 2023 | 171 | 0.180 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2021 | 4 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1231 | 0.180 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2021 | 10 | 0.180 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2021 | 16 | 0.180 |
Why?
|
| MRE11 Homologue Protein | 2 | 2020 | 8 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 175 | 0.180 |
Why?
|
| Animals | 6 | 2024 | 21381 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 410 | 0.170 |
Why?
|
| Hydroxyurea | 1 | 2020 | 19 | 0.160 |
Why?
|
| Zebrafish | 1 | 2023 | 374 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2020 | 120 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 446 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 132 | 0.150 |
Why?
|
| Phosphorylation | 2 | 2020 | 962 | 0.150 |
Why?
|
| Genes, ras | 1 | 2019 | 28 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 198 | 0.140 |
Why?
|
| Carcinogens | 1 | 2018 | 33 | 0.140 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2019 | 83 | 0.140 |
Why?
|
| Cell Survival | 1 | 2020 | 587 | 0.140 |
Why?
|
| Integrases | 3 | 2003 | 41 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2020 | 422 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2009 | 1225 | 0.140 |
Why?
|
| Organ Specificity | 1 | 2018 | 200 | 0.130 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 256 | 0.130 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2016 | 7 | 0.120 |
Why?
|
| Viral Proteins | 3 | 2003 | 270 | 0.120 |
Why?
|
| Mice, Knockout | 1 | 2021 | 2162 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2016 | 56 | 0.120 |
Why?
|
| Melanoma | 1 | 2019 | 333 | 0.110 |
Why?
|
| Spindle Poles | 1 | 2014 | 1 | 0.110 |
Why?
|
| RNA, Satellite | 1 | 2014 | 2 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 642 | 0.110 |
Why?
|
| Binding Sites | 4 | 2013 | 916 | 0.110 |
Why?
|
| Recombinational DNA Repair | 1 | 2014 | 29 | 0.110 |
Why?
|
| Centrosome | 1 | 2014 | 72 | 0.110 |
Why?
|
| RNA Helicases | 1 | 2015 | 99 | 0.100 |
Why?
|
| Models, Genetic | 1 | 2015 | 267 | 0.100 |
Why?
|
| Cell Line | 3 | 2016 | 2024 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 982 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 790 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 210 | 0.100 |
Why?
|
| Breast | 1 | 2014 | 192 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 586 | 0.090 |
Why?
|
| Replication Protein C | 1 | 2011 | 8 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 89 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1387 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2188 | 0.080 |
Why?
|
| CDC2 Protein Kinase | 1 | 2009 | 38 | 0.070 |
Why?
|
| S Phase | 1 | 2009 | 79 | 0.070 |
Why?
|
| DNA | 2 | 2004 | 852 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2016 | 1557 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1631 | 0.060 |
Why?
|
| Epithelium | 1 | 2025 | 100 | 0.060 |
Why?
|
| Plasmids | 2 | 2002 | 294 | 0.050 |
Why?
|
| Virus Integration | 1 | 2004 | 33 | 0.050 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2023 | 1 | 0.050 |
Why?
|
| Male | 2 | 2023 | 31187 | 0.050 |
Why?
|
| Models, Biological | 3 | 2004 | 1192 | 0.050 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2003 | 4 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 293 | 0.050 |
Why?
|
| Semen | 1 | 2023 | 50 | 0.050 |
Why?
|
| Meiosis | 1 | 2023 | 80 | 0.050 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2002 | 7 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 120 | 0.050 |
Why?
|
| Testis | 1 | 2023 | 160 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 49 | 0.050 |
Why?
|
| Biological Assay | 1 | 2002 | 56 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 399 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 129 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2020 | 3155 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2002 | 315 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 672 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 426 | 0.040 |
Why?
|
| Chromatin | 1 | 2024 | 643 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 178 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 463 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 215 | 0.040 |
Why?
|
| Substrate Specificity | 3 | 2004 | 341 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 55 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1290 | 0.030 |
Why?
|
| Acetaldehyde | 1 | 2016 | 4 | 0.030 |
Why?
|
| Formaldehyde | 1 | 2016 | 33 | 0.030 |
Why?
|
| Cisplatin | 1 | 2016 | 145 | 0.030 |
Why?
|
| Protein Binding | 2 | 2013 | 1632 | 0.030 |
Why?
|
| Transcription Termination, Genetic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Multifunctional Enzymes | 1 | 2015 | 19 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 403 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 700 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 541 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 644 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 2 | 2004 | 241 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 1233 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 617 | 0.020 |
Why?
|
| Base Sequence | 2 | 2004 | 1331 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 907 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 43 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1575 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 713 | 0.020 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2006 | 6 | 0.010 |
Why?
|
| DNA Repair Enzymes | 1 | 2006 | 38 | 0.010 |
Why?
|
| DNA, Cruciform | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 2004 | 25 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 102 | 0.010 |
Why?
|
| Metals | 1 | 2004 | 65 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 254 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 317 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2002 | 101 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2006 | 718 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1979 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2002 | 1155 | 0.010 |
Why?
|